VYLOY 100 MG INF PLV CSL 1
What is the maximum co-payment for VYLOY?
If the insurance company contributes, the maximum co-payment is 1 085,97 Kč. The maximum pharmacy price is 14 828,04 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.
Does the medicine have reimbursement from public health insurance?
A medicine whose use is, in the public interest, appropriate to concentrate in specialized facilities pursuant to Section 15(10) of the Public Health Insurance Act. The medicine is reimbursed as ZÚLP and only from a facility that has a contract with the health insurer.
Does VYLOY have a counted co-payment set?
No, this medicine has no counted co-payment.
How much does the insurance company pay for one dispensed reimbursed pack?
13 742,07 Kč.
Does the insurance company pay a higher amount in some cases?
No, the medicine has no increased reimbursement.
Does the medicine have an indication restriction?
Is it available without a medical prescription?
No, the medicine cannot be obtained without a prescription.
Which medical specialist may prescribe VYLOY?
Prescription is not conditional on a medical specialization.
What is the composition of VYLOY?
SÚKL does not provide composition information for this medicine.
Where can I find information about correct use of the medicine?
- Documents could not be found
Which medicines are similar to VYLOY?
The medicine belongs to ATC group L01FX31 – ZOLBETUXIMAB. Medicines with the same active substance can be found here.
Who manufactures VYLOY?
Astellas Pharma Europe B.V., Leiden (NL)
Is the medicine in shortage?
The latest report from the manufacturer is from 6. 11. 2025. Production has been officially started as of 7. 11. 2025.
What is the unique code for VYLOY?
The medicine has code 0272829. Code details can be found here.
How many packs of VYLOY were previously dispensed on prescriptions in Czechia?
Show prescription medicine consumption
How many packs of VYLOY were previously dispensed on request forms in Czechia?
PODOBNÉ PŘÍPRAVKY:
The page was last updated on 03. 05. 2026